Oramed Pharmaceuticals Inc.
ORMP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19 | $6 | -$37 | -$22 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $3 | -$3 | -$1 | -$1 |
| Other Non-Cash | $7 | -$13 | $9 | $2 |
| Operating Cash Flow | -$8 | -$10 | -$29 | -$21 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $2 |
| Inv. Purchases | -$56 | -$191 | -$154 | -$54 |
| Inv. Sales/Matur. | $162 | $118 | $185 | $30 |
| Other Inv. Act. | -$0 | $0 | $0 | -$0 |
| Investing Cash Flow | $106 | -$73 | $30 | -$22 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$50 | $50 | – | – |
| Stock Issued | $0 | $2 | $12 | $101 |
| Stock Repurch. | -$2 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $0 | $0 | $0 |
| Financing Cash Flow | -$52 | $52 | $12 | $101 |
| Forex Effect | -$0 | -$0 | -$50 | $0 |
| Net Chg. in Cash | $45 | -$31 | -$37 | $58 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9 | $40 | $77 | $19 |
| End Cash | $54 | $9 | $40 | $77 |
| Free Cash Flow | -$8 | -$11 | -$29 | -$22 |